Search
Dermata Therapeutics Inc
DRMAAdd to Watchlist
1.150USD
0.0000.00%
Market hours 09/22, 15:47（ET）
4.62MMarket Cap
LossP/E TTM
DRMA Financials
See Dermata Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
4.62M
Dividend TTM
0.00
P/E TTM
-0.28
EPS TTM
-4.17
Revenue
--
Net Profit
-12.29M
ROE
-103.58%
ROA
-81.31%
Dermata Therapeutics Inc Earnings Date
Latest Release
Aug 11, 2026
EPS / Forecast
-0.74/-0.55
Revenue / Forecast
--/0.00
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its current assets were 7.86M, with a year-on-year change of 122.53.
What are the total assets of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its total assets of Dermata Therapeutics Inc were 7.86M, with a year-on-year change of 122.53.
What are the total liabilities of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its total liabilities of Dermata Therapeutics Inc were 1.64M, with a year-on-year change of -16.85.
What is the total equity of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its total equity of Dermata Therapeutics Inc was 6.22M, with a year-on-year change of 298.66.
What is the net operating income of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its net operating income of Dermata Therapeutics Inc was -7.77M, with a year-on-year change of 37.88.
What is the net financing of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its net financing of Dermata Therapeutics Inc was 12.12M, with a year-on-year change of 75.97.
What is the Earnings Per Share (EPS) of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.16, with a year-on-year change of 89.84.
What is the net income of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its net income was -7.56M, with a year-on-year change of 38.49.
What is the Return on Equity (ROE) of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -194.20, with a year-on-year change of 37.45.
What is the Return on Assets (ROA) of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -132.63, with a year-on-year change of 37.87.
What is the operating profit of Dermata Therapeutics Inc?
According to Dermata Therapeutics Inc's FY2025 earnings report, its operating profit was -7.77M, with a year-on-year change of 37.88.